Daily Archives: February 17, 2022
Cohort study: Protection against SARS-CoV-2 after Covid-19 vaccination lasts longer in patients with previous infection.
17 Feb, 2022 | 10:11h | UTC
RCT: Oral Nirmatrelvir for high-risk adults with Covid-19 reduces the risk of hospitalization by 89%.
17 Feb, 2022 | 10:14h | UTCAudio Interview: A New Antiviral against Covid-19 – new England Journal of Medicine
Related:
Commentary on Twitter
The Paxlovid pill (Nirmatrelvir) randomized, placebo-controlled trial published @NEJM:
89% efficacy vs Covid hospitalizations or deaths, and quick reduction of viral load.
The active pills had less serious adverse events or discontinuations than placebohttps://t.co/HBMRZt4wBo pic.twitter.com/LDQv41O56c— Eric Topol (@EricTopol) February 16, 2022
Retrospective cohort study: Pfizer vaccine reduces the risk of reinfection after recovery from Covid-19.
17 Feb, 2022 | 10:13h | UTCEffectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 – New England Journal of Medicine
Commentary on Twitter
Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection. https://t.co/AAlsY9sFlv pic.twitter.com/Nkj1lP77ZW
— NEJM (@NEJM) February 16, 2022
Meta-analysis finds the overall prevalence of statin intolerance is around 9% and identifies the most common risk factors.
17 Feb, 2022 | 10:07h | UTCPrevalence of statin intolerance: a meta-analysis – European Heart Journal
Commentaries:
Expert reaction to study looking at statin intolerance – Science Media Centre
Related:
Commentary on Twitter
Statin intolerance is “over-estimated and over-diagnosed”. World’s largest study shows less than 10% suffer side-effects caused by statins https://t.co/pcVk8YI3I3@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #Riskfactors pic.twitter.com/b3nFWsc74d
— European Society of Cardiology Journals (@ESC_Journals) February 16, 2022
England to offer Covid jab to five to 11-year-olds.
17 Feb, 2022 | 10:09h | UTCEngland to offer Covid jab to five to 11-year-olds – BBC
Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.
17 Feb, 2022 | 09:58h | UTCCommentary: Studies detail risk of severe COVID-19, GI problems in kids – CIDRAP
Commentary on Twitter
The risk of intensive care unit admission among children with COVID-19 is affected by age, ethnicity and comorbidities, according to a @NatureMedicine paper. Understanding these modifiers might help identify at-risk children and guide interventions. https://t.co/MIkLecyNI6 pic.twitter.com/JtN3Ab4Lu7
— Nature Portfolio (@NaturePortfolio) December 20, 2021
Review: Diagnosis and treatment of acute coronary syndromes.
17 Feb, 2022 | 10:04h | UTCDiagnosis and Treatment of Acute Coronary Syndromes: A Review – JAMA (free for a limited period)
Audio clinical review: Diagnosis and Treatment of Acute Coronary Syndromes – JAMA
How COVID-19 transformed genomics and changed the handling of disease outbreaks forever.
17 Feb, 2022 | 09:56h | UTC
Review | Wastewater network infrastructure in public health: Applications and learnings from the COVID-19 pandemic.
17 Feb, 2022 | 09:54h | UTCRelated:
Opinion: Wastewater analysis can be a powerful public health tool—if it’s done sensibly.
CDC unveils its latest weapon in Covid-19 detection: wastewater.
[Preprint] Wastewater genomic testing can effectively track COVID-19 variants of concern.
Human Waste Could Be The Next Big Weapon in Controlling COVID-19 – TIME
Next steps for wastewater testing to help end this pandemic — and prevent the next one – STAT
The myriad ways sewage surveillance is helping fight COVID around the world – Nature
It’s time to begin a national wastewater testing program for Covid-19 – STAT
Coronavirus: Testing sewage an ‘easy win’ – BBC
German Guidelines for the diagnosis, therapy and follow-up of cervical cancer – Part 1 with recommendations on epidemiology, screening, diagnostics and therapy.
17 Feb, 2022 | 08:47h | UTC
SIMEU position paper on non-invasive respiratory support in COVID-19 pneumonia.
17 Feb, 2022 | 10:01h | UTCRelated:
ASCRS Guidelines for the management of colon cancer.
17 Feb, 2022 | 08:49h | UTC
Commentary on Twitter
This #DCRJournal highlights CPG: Colon Cancer – see all in these visual abstracts: https://t.co/qGE9lqZiIc@JonVogel7 @a_bham18 @alexhawkinsmd @seanlangenfeld @ajthorsenL @ColonCancerDoc @AmyLightnerMD @ianmpaquette @KyleCologne @SamAtallahMD @debby_keller @SeanLangenfeld pic.twitter.com/xqLeCF0lGz
— DCRjournal (@DCRjournal) February 7, 2022
Guidance for systematic integration of undernutrition in attributing cause of death in children.
17 Feb, 2022 | 08:46h | UTC
Consensus Recommendations: Development of a swallowing risk screening tool and best practice recommendations for the management of oropharyngeal dysphagia following acute cervical spinal cord injury.
17 Feb, 2022 | 08:40h | UTC
Perspective | The hidden epidemic: Antibiotic resistance is approaching a crisis point, and the world needs to act.
17 Feb, 2022 | 08:39h | UTCRelated: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Mortality and clinical cure rates for pneumonia: a systematic review, meta-analysis, and trial sequential analysis of randomized control trials comparing bactericidal and bacteriostatic antibiotic treatments.
17 Feb, 2022 | 08:35h | UTC
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomized evidence.
17 Feb, 2022 | 08:37h | UTC
Supportive care needs of men with prostate cancer: A systematic review of qualitative studies.
17 Feb, 2022 | 08:34h | UTC
RCT: L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy.
17 Feb, 2022 | 08:35h | UTCL-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial – Hepatology (link to abstract – $ for full-text)
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.
17 Feb, 2022 | 08:31h | UTC
Central vs. peripheral vision loss in emergency medicine.
17 Feb, 2022 | 08:32h | UTCCentral vs. Peripheral Vision Loss – emDocs
Treatment options after a diagnosis of early miscarriage: expectant, medical, and surgical.
17 Feb, 2022 | 08:24h | UTC
M-A: Impact of pharmacist-led antimicrobial stewardship on appropriate antibiotic prescribing in the emergency department.
17 Feb, 2022 | 08:23h | UTCImpact of Pharmacist-Led Antimicrobial Stewardship on Appropriate Antibiotic Prescribing in the Emergency Department: A Systematic Review and Meta-Analysis – Annals of Emergency Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Hot off the Press: Impact of Pharmacist-Led Antimicrobial
Stewardship on Appropriate Antibiotic Prescribing
in the Emergency Department: A Systematic
Review and Meta-Analysis https://t.co/NsZIubli8z pic.twitter.com/V2Sf6tLoKI— AnnalsofEM (@AnnalsofEM) January 24, 2022
Dupuytren’s Disease—etiology and treatment.
17 Feb, 2022 | 08:25h | UTCDupuytren’s Disease—Etiology and Treatment – Deutsches Ärzteblatt International
Prone positioning during venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a pooled individual patient data analysis.
17 Feb, 2022 | 08:19h | UTC